We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Qiagen NV (QGEN) EUR0.01

Sell:$46.62 Buy:$46.63 Change: $1.80 (4.02%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Sell:$46.62
Buy:$46.63
Change: $1.80 (4.02%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Sell:$46.62
Buy:$46.63
Change: $1.80 (4.02%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Contact details

Address:
Hulsterweg 82
VENLO
5912 PL
Netherlands
Telephone:
+31 (77) 3556600
Website:
https://www.qiagen.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
QGEN
ISIN:
NL0012169213
Market cap:
$9.96 billion
Shares in issue:
227.45 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
Netherlands
Currency:
US dollar
Indices:
n/a

Key personnel

  • Lawrence Rosen
    Independent Chairman of the Supervisory Board
  • Thierry Bernard
    Chief Executive Officer, Managing Director, Member of the Executive Board
  • Roland Sackers
    Managing Director, Chief Financial Officer, Member of the Executive Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.